Format

Send to

Choose Destination
Anticancer Res. 2015 Aug;35(8):4545-9.

Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports.

Author information

1
Department of Life System, Institute of Technology and Science, Graduate School, Tokushima University, Tokushima, Japan Saisei Mirai Cell Processing Center, Osaka, Japan Inui Immunotherapy Clinic, Osaka, Japan contact@saisei-mirai.or.jp.
2
Saisei Mirai Cell Processing Center, Osaka, Japan.
3
Department of Life System, Institute of Technology and Science, Graduate School, Tokushima University, Tokushima, Japan Saisei Mirai Cell Processing Center, Osaka, Japan.
4
Department of Life System, Institute of Technology and Science, Graduate School, Tokushima University, Tokushima, Japan.
5
Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Japan.
6
Division of Food and Drug Evaluation Science, Department of Community Medicine and Social Healthcare Science, Graduate School of Medicine, Kobe University, Kobe, Japan.
7
Inui Immunotherapy Clinic, Osaka, Japan contact@saisei-mirai.or.jp.

Abstract

BACKGROUND:

Gc protein-derived macrophage-activating factor (GcMAF) immunotherapy has been steadily advancing over the last two decades. Oral colostrum macrophage-activating factor (MAF) produced from bovine colostrum has shown high macrophage phagocytic activity. GcMAF-based immunotherapy has a wide application for use in treating many diseases via macrophage activation or for use as supportive therapy.

RESULTS:

Three case studies demonstrate that oral colostrum MAF can be used for serious infection and chronic fatigue syndrome (CFS) without adverse effects.

CONCLUSION:

We demonstrate that colostrum MAF shows promising clinical results in patients with infectious diseases and for symptoms of fatigue, which is common in many chronic diseases.

KEYWORDS:

Immunotherapy; cancer; chronic fatigue syndrome (CFS); colostrum; macrophage-activating factor (MAF); myalgic encephalomyelitis (ME)

PMID:
26168499
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center